Contact this trialFirst, we need to learn more about you.
Norepinephrine Reuptake Inhibitor
AXS-12 for Narcolepsy
Recruiting1 awardPhase 3
Doral, Florida
This trial tests AXS-12, a medication for people with narcolepsy who have sudden muscle weakness and excessive daytime sleepiness. It aims to help them stay awake during the day and reduce muscle weakness episodes. Pitolisant is a new drug approved to treat excessive daytime sleepiness and cataplexy in narcolepsy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service